October 4, 2018 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it is holding a design competition in collaboration with the Janesville School District. The competition asks students to create a 3D-printed object to be used by SHINE as an employee award of excellence, titled The Illuminator Award. Students in the 6th-12thgrades in the School District of Janesville, including Janesville homeschoolers and religious schools, are eligible to compete. This collaboration aligns with the district’s recent work to transition to a STEAM-focused (science, technology, engineering, art and math) education culture.
“SHINE is very excited to engage with the next generation of students in our community,” says Cheryl Peterson, SHINE’s Community and Employee Engagement Manager. “We want to help students understand the importance of science, technology, engineering, art and math in preparing them for future careers, not only at SHINE, but for countless other careers.”
“Our teachers are working hard to transform instruction in their classrooms, emphasizing work that gets students more engaged in their learning, empowering them for their future,” said Steve Pophal, Superintendent of the School District of Janesville. “Partnering with SHINE on this contest helps our students make the connection between what they learn in the classroom and the real world needs of the community at large.”
Teams of no more than four students will be judged by SHINE on their design and awarded points based on usefulness, innovation/creativity and SHINE-y-ness (that which most resembles SHINE technology). Teams must sign up at SHINEmed.com/illuminator_awardby October 15, 2018 and submit their final 3D design product by January 18, 2019. For more information on specifications and other details, visit SHINEmed.com/illuminator_award.
The 2019 SHINE Illuminator Award 3D Design Competition winning team will receive a VIP Behind the Scenes Tour of SHINE Building One, 4027 N Riverside Drive, and 3D printing supplies for their school.
Molybdenum-99 (Mo-99) is a radioisotope that decays into the diagnostic imaging agent technetium‑99m (Tc-99m). Tc-99m is used in more than 40 million medical imaging procedures each year, primarily in stress tests to diagnose heart disease and bone scans to stage cancer. SHINE was founded to deploy a safe, cost-effective and environmentally friendly technology to produce medical isotopes, including Mo‑99.
About SHINE Medical Technologies, Inc.
Founded in 2010, SHINE is a development-stage company working toward becoming a manufacturer of radioisotopes for nuclear medicine. The SHINE system uses a patented, proprietary manufacturing process that offers major advantages over existing and proposed production technologies, as it does not require a nuclear reactor, uses less electricity, generates less waste and is compatible with the nation’s existing supply chain for molybdenum-99. In 2014, SHINE announced the execution of molybdenum-99 supply agreements with GE Healthcare and Lantheus Medical Imaging. In 2015, with the help of Argonne National Laboratory, GE Healthcare demonstrated SHINE molybdenum-99 can act as a drop-in replacement for reactor-based moly-99. In 2016, SHINE received regulatory approval to construct its facility from the Nuclear Regulatory Commission and signed a moly-99 supply agreement with HTA Co., Ltd., the largest Chinese distributor of radiopharmaceuticals. Learn more at http://shinetechnologies.com.